Suzuki Motor Corp said it has sold its entire 1.5 percent stake in Volkswagen AG to Porsche Automobil Holding SE and will post a special profit of 36.7 billion yen ($304 million) on the transaction.
The Financial Stability Board promises to draft rules that would prevent taxpayers having to bail out financial institutions by the time of the G-20 summit in November.
Tresiba is already being sold in 30 countries, and analysts expect annual sales of $2.4 billion by 2020, according to Thomson Reuters Cortellis.
“We would no longer recommend the vehicle as an eco-conscious pick."
For the week, the Dow was down 0.4 percent, the S&P 500 was down 1.4 percent and the Nasdaq was down 2.9 percent.
A Fed representative would not comment on whether Janet Yellen planned to see a doctor for a follow-up check-up following health concerns during a trip to Massachusetts.
As Matthias Mueller took the helm of the troubled German automaker, the country's transport minister announced that Volkswagen had manipulated test results for about 2.8 million vehicles in Germany, nearly six times as many as in the U.S.
Fed Chair Janet Yellen assured markets that interest rates would rise in 2015, but she also had a message for workers.
Thousands of women have filed complaints with the FDA about the Essure device since it was approved in 2002.
As Volkswagen's diesel deception comes to light, critics say it's time to revamp auto emissions testing.
The world’s largest automaker does well in emerging markets and Europe, but it’s been struggling since 2012 in the U.S. The emissions-cheating scandal won't help.
Wall Street predicts that House Majority Leader John Boehner's resignation made a government shutdown next week less likely. December is another story.
John German, senior fellow at the ICCT, tells International Business Times he alerted the feds to the problem in 2014.
Even with the announcement of meaningful greenhouse gas emissions reforms, China faces myriad problems in reducing its carbon footprint.
Unexpectedly good gross domestic product numbers from the U.S. Commerce Department lifted stocks Friday morning.
Celebrities and voters had plenty to say about the presidential candidate's comments that he can appeal to African-American voters without "free stuff."
Many urban areas are seeing a growing white population for the first time in years.
Following last week's damning revelations, the list of countries that have launched investigations into the carmaker’s malpractices has continued to grow.
Hillary Clinton has said she'd allow Americans to buy medicines from any country if they are cheaper there, and safe.
In China, however, the Shanghai Composite Index fell 1.6 percent, ending a day of volatile trading on Asian bourses.
A senior official of the country's state-run oil firm told the Wall Street Journal that oil exports are likely to increase by 500,000 barrels a day by late November or early December.
Data released before markets opened showed Japan's core consumer prices marked the first annual drop since the central bank deployed a stimulus program.
If inflation is stable and a stronger economy can boost employment, the U.S. Federal Reserve Board will raise interest rates later this year, its chairwoman said.
The Secret Service reported that the Fed chairwoman was feeling better after experiencing lightheadedness in Amherst, Massachussets, a report said.
Investors were cautious ahead of a speech by Federal Reserve Chairwoman Janet Yellen, scheduled for 5 p.m. EDT Thursday.
As customer anger mounts, Volkswagen’s past claims about its diesel vehicles could add to its legal woes.
In announcing a historic redlining settlement Thursday, government officials said more companies are under investigation for discriminatory lending.
Amid political fury over the high cost of prescription drugs, there’s one controversial solution that no candidate has proposed –- price controls.
Critics say lax regulations at the Environmental Protection Agency made it easier for Volkswagen to game the system.
Pricey medicines in the U.S. actually subsidize research and development for the rest of the world, where patients pay less for the same drugs.